<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xsi:schemaLocation="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2022v5.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2023-11-15T12:53:33-06:00</ReturnTs>
    <TaxPeriodEndDt>2022-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmName>
        <BusinessNameLine1Txt>FORVIS LLP</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>8200 W Interstate 10 Suite 900</AddressLine1Txt>
        <CityNm>San Antonio</CityNm>
        <StateAbbreviationCd>TX</StateAbbreviationCd>
        <ZIPCd>782303806</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2022-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>237379332</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>SOUTH TEXAS BLOOD &amp; TISSUE CENTER</BusinessNameLine1Txt>
      </BusinessName>
      <InCareOfNm>% BENJAMIN LOPEZ</InCareOfNm>
      <BusinessNameControlTxt>SOUT</BusinessNameControlTxt>
      <PhoneNum>2107579505</PhoneNum>
      <USAddress>
        <AddressLine1Txt>6211 IH 10 WEST</AddressLine1Txt>
        <CityNm>SAN ANTONIO</CityNm>
        <StateAbbreviationCd>TX</StateAbbreviationCd>
        <ZIPCd>78201</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>JOHN YOUNGDAHL</PersonNm>
      <PersonTitleTxt>SVP, CFO</PersonTitleTxt>
      <PhoneNum>2107579505</PhoneNum>
      <SignatureDt>2023-11-15</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <SigningOfficerGrp>
      <PersonFullName>
        <PersonFirstNm>JOHN</PersonFirstNm>
        <PersonLastNm>YOUNGDAHL</PersonLastNm>
      </PersonFullName>
      <SSN>999009999</SSN>
    </SigningOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>Roberto Ulloa</PreparerPersonNm>
      <PTIN>P01953132</PTIN>
      <PhoneNum>2103419400</PhoneNum>
      <PreparationDt>2023-11-15</PreparationDt>
    </PreparerPersonGrp>
    <AdditionalFilerInformation>
      <TrustedCustomerGrp>
        <TrustedCustomerCd>3</TrustedCustomerCd>
      </TrustedCustomerGrp>
    </AdditionalFilerInformation>
    <TaxYr>2022</TaxYr>
    <BuildTS>2023-04-26 12:10:37Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="9">
    <IRS990 documentId="IRS990" referenceDocumentId="IRS990ScheduleO">
      <PrincipalOfficerNm>MARTIN J LANDON</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>6211 IH 10 WEST</AddressLine1Txt>
        <CityNm>SAN ANTONIO</CityNm>
        <StateAbbreviationCd>TX</StateAbbreviationCd>
        <ZIPCd>78201</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>96309531</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.SOUTHTEXASBLOOD.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1973</FormationYr>
      <LegalDomicileStateCd>TX</LegalDomicileStateCd>
      <ActivityOrMissionDesc>THE SOUTH TEXAS BLOOD &amp; TISSUE CENTER SUPPLIES BLOOD TO MORE THAN 100 HOSPITALS IN SOUTH TEXAS AND SUPPORTS TISSUE, RESEARCH/NEW THERAPIES AND UMBILICAL (SEE SCHEDULE O)</ActivityOrMissionDesc>
      <ContractTerminationInd>X</ContractTerminationInd>
      <VotingMembersGoverningBodyCnt>1</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>0</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>408</TotalEmployeeCnt>
      <TotalVolunteersCnt>8</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>0</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>854201</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>1395028</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>130613417</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>94236236</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>-4447</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>40633</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>378184</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>637634</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>131841355</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>96309531</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>0</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>439561</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>22640423</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>24142974</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>0</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>91489256</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>72099464</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>114129679</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>96681999</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>17711676</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>-372468</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>60738995</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>49876428</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>51940835</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>51734755</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>8798160</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>-1858327</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>THE SOUTH TEXAS BLOOD &amp; TISSUE CENTER SUPPLIES BLOOD TO MORE THAN 100 HOSPITALS IN SOUTH TEXAS AND SUPPORTS TISSUE, RESEARCH/NEW THERAPIES, AND UMBILICAL CORD BLOOD/BIRTH TISSUE DONATIONS.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>true</SignificantChangeInd>
      <ExpenseAmt>52392804</ExpenseAmt>
      <RevenueAmt>76038789</RevenueAmt>
      <Desc>THE SOUTH TEXAS BLOOD &amp; TISSUE CENTER (STBTC) SPECIALIZES IN COLLECTING AND PROVIDING LIFE-SAVING BLOOD AND BLOOD COMPONENTS TO HOSPITALS AND PATIENTS IN THE SOUTH TEXAS REGION AND BEYOND. WE MEET THIS COMMITMENT THROUGH OUR GENEROUS DONORS, WHO HELP SAVE LIVES EVERY DAY BY GIVING OF THEMSELVES. STBTC DREW NEARLY 121,248 LIFE-SAVING RED BLOOD CELL UNITS AND NEARLY 22,419 PLATELET UNITS IN 2022. THE CENTER FOR ADVANCED THERAPIES INCLUDES THE LIFE LEGACIES TISSUE DEPT., APHERESIS SERVICES, THE CORD BLOOD/BIRTH TISSUE PROGRAM AND CLINICAL &amp; RESEARCH OPERATIONS. THE LIFE LEGACIES TISSUE DEPARTMENT GREW OVERALL DONORS RECOVERED BY 2.2% AND SKIN TISSUE RECOVERIES BY 50% IN 2022 OVER THE PRIOR YEAR. TISSUE DONATION HELPS SAVE AND IMPROVE THE LIVES OF COUNTLESS INDIVIDUALS IN NEED OF TRANSPLANTS AND MEDICAL TREATMENTS. BLOOD &amp; TISSUE CENTER FOUNDATION FUNDING HELPED TO SEND A DONOR'S FAMILY TO THE ROSE BOWL PARADE IN PASADENA, CA, WHERE THEY RODE THE "DONATE LIFE" FLOAT AND A BEAUTIFUL FLORAGRAPH PICTURE OF THEIR LOVED ONE WAS ALSO ON THE FLOAT. OUR TISSUE PROGRAM HAS PLAYED A PIVOTAL ROLE IN EDUCATING THE PUBLIC ABOUT THE IMPORTANCE OF TISSUE DONATION AND IS SUCCESSFULLY INCREASING THE NUMBER OF REGISTERED TISSUE DONORS IN SOUTH TEXAS, CONTRIBUTING TO A LARGER DONOR POOL AND PROVIDING HOPE TO THOSE AWAITING LIFE-SAVING TREATMENTS. OUR APHERESIS PROGRAM BECAME FACT (FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY) ACCREDITED IN FEBRUARY 2022! 169 PERIPHERAL BLOOD STEM CELL (PBSC) AND MONONEUCLEIC CELL (MNC) COLLECTIONS WERE PROVIDED TO PATIENTS FOR BONE MARROW TRANSPLANTS FROM OUR PROGRAM. FUNDS FROM FOUNDATION DONORS ASSISTED IN A MEETING OF A DONOR AND A RECIPIENT IN LONDON IN 2022 AS THE RECIPIENT ASKED THE LIFE-SAVING DONOR TO ATTEND HER WEDDING. THIS PBSC DONOR IS ALSO A STAFF MEMBER OF OUR BE THE MATCH PROGRAM. THE APHERESIS CENTER ALSO HAD 44 MNC COLLECTIONS IN 2022 THAT WERE USED FOR RESEARCH. THE CORD BLOOD &amp; BIRTH TISSUE PROGRAMS SENT 11 LIFE SAVING CORD BLOOD UNITS FOR TRANSPLANT IN 2022 AND BANKED ANOTHER 31 UNITS FOR POTENTIAL FUTURE USE. CORD BLOOD CONTAINS STEM CELL WHICH CAN BE USED TO TREAT A VARIETY OF DISEASES AND CONDITIONS INCLUDING LEUKEMIA, LYMPOHOMA, SICKLE CELL ANEMIA AND MORE. CORD BLOOD HAS BEEN USED TO TREAT OVER 80 DIFFERENT DISEASES AND DISORDERS. 874 UNITS OF BIRTH TISSUE (PLACENTA &amp; CORD TISSUE) WERE COLLECTED IN 2022. BIRTH TISSUE CONTAINS MESENCHYMAL STEM CELLS, WHICH HAVE THE ABILITY TO DIFFERENTIATE INTO A VARIETY OF CELL TYPES TO TREAT CONDITIONS SUCH AS ARTHRITIS, SPINAL CORD INJURIES AND DAMAGED TISSUE. BIRTH TISSUE ALSO PROVIDES ANTI-INFLAMMATORY FACTORS, CYTOKINES AND GROWTH FACTOR THAT PROMOTE AND ENHANCE TISSUE HEALTH. CORD BLOOD AND BIRTH TISSUE HAVE THE POTENTIAL TO SAVE COUNTLESS LIVES WHERE ONE PERSON'S DONATION HEALS MANY. CLINICAL &amp; RESEARCH OPERATIONS PERFORMED 650 RESEARCH COLLECTIONS IN 2022 FOR A VARIETY OF PROGRAMS AND STUDIES. OUR RESEARCH DONOR REGISTRY GREW TO 25,000+ POTENTIAL DONORS. WE ARE IN PARTNERSHIP WITH ALL OF US, A RESEARCH PROGRAM FROM THE NATIONAL INSTITUTES OF HEALTH FOR WHICH WE COLLECTED 155 BIOSAMPLES IN 2022. ALL OF US AIMS TO HAVE ONE MILLION OR MORE VOLUNTEERS WHO REFLECT THE DIVERSITY OF THE US. RESEARCHERS MAY USE THE PARTICIPANT DATA COLLECTED TO STUDY MANY DIFFERENT CONDITIONS, INCLUDING CANCER, DIABETES, DEPRESSION, ASTHMA, AND OTHER DISEASES. AS RESEARCHERS STUDY OUR HEALTH DATA, THEY MAY FIND PATTERNS. THESE PATTERNS CAN HELP THEM UNDERSTAND HOW DIFFERENT PEOPLE REACT TO DIFFERENT PREVENTION AND TREATMENT PLANS. OUR PARTICIPATION IS A WONDERFUL OPPORTUNITY FOR SOUTH TEXAS BLOOD &amp; TISSUE TO CONTINUE TO LEAD THE WAY TO BETTER HEALTH FOR OUR COMMUNITY AND BEYOND.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>21587902</ExpenseAmt>
        <RevenueAmt>18835081</RevenueAmt>
        <Desc>COMMUNITY LABS IS A DISREGARDED NON-PROFIT ORGANIZATION THAT WORKS TO CREATE COVID-19 SAFETY ZONES AND A PATHWAY FOR SCHOOLS TO REOPEN, PEOPLE TO RETURN TO WORK AND COMMUNITIES TO RECOVER. TO ACHIEVE OUR MISSION, WE WORK WITH A LOCAL SPECIALIZED LAB THAT PROVIDES 24-HOUR TEST RESULTS AND A LESS INVASIVE TEST BY SWABBING THE FRONT OF THE NOSTRIL. ON JULY 1ST, 2022, THE MANAGING MEMBER CHANGED FROM SOUTH TEXAS BLOOD &amp; TISSUE CENTER TO AN UNRELATED NON-PROFIT.</Desc>
      </ProgSrvcAccomActy2Grp>
      <TotalProgramServiceExpensesAmt>73980706</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="IRS990ScheduleA">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="IRS990ScheduleB">true</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>false</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="IRS990ScheduleD">false</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="IRS990ScheduleD">false</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="IRS990ScheduleD">false</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="IRS990ScheduleD">false</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd referenceDocumentId="IRS990ScheduleD">false</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="IRS990ScheduleD">true</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="IRS990ScheduleD">false</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="IRS990ScheduleD">false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="IRS990ScheduleD">true</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="IRS990ScheduleD">true</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="IRS990ScheduleD">false</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="IRS990ScheduleD">false</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="IRS990ScheduleD">true</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd>false</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>false</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>false</FundraisingActivitiesInd>
      <GamingActivitiesInd>false</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="IRS990ScheduleI">true</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="IRS990ScheduleI">false</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="IRS990ScheduleJ">true</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>false</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>false</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>false</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>false</DeductibleArtContributionInd>
      <TerminateOperationsInd referenceDocumentId="IRS990ScheduleN">false</TerminateOperationsInd>
      <PartialLiquidationInd referenceDocumentId="IRS990ScheduleN">true</PartialLiquidationInd>
      <DisregardedEntityInd referenceDocumentId="IRS990ScheduleR">true</DisregardedEntityInd>
      <RelatedEntityInd referenceDocumentId="IRS990ScheduleR">true</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>true</RelatedOrganizationCtrlEntInd>
      <TransactionWithControlEntInd referenceDocumentId="IRS990ScheduleR">true</TransactionWithControlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd referenceDocumentId="IRS990ScheduleR">false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd referenceDocumentId="IRS990ScheduleR">false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <IRPDocumentCnt>70</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>true</BackupWthldComplianceInd>
      <EmployeeCnt>408</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>true</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>false</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>false</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>false</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>1</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>0</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>true</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>false</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>false</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>true</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>true</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>true</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>true</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>true</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>false</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>false</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>BENJAMIN LOPEZ</PersonNm>
        <PhoneNum>2107579505</PhoneNum>
        <USAddress>
          <AddressLine1Txt>6211 IH 10 WEST</AddressLine1Txt>
          <CityNm>SAN ANTONIO</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>78201</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <InfoInScheduleOPartVIIInd>X</InfoInScheduleOPartVIIInd>
      <Form990PartVIISectionAGrp>
        <PersonNm>ADRIENNE MENDOZA</PersonNm>
        <TitleTxt>SVP, COO STBT (EFF 04/22)</TitleTxt>
        <AverageHoursPerWeekRt>49.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.0</AverageHoursPerWeekRltdOrgRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>299073</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>27478</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SAMANTHA GOMEZ NGAMSUNTIKUL</PersonNm>
        <TitleTxt>ASSOCIATE MEDICAL DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>50.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>252106</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>34975</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>HARRY DANIEL IRIZARRY</PersonNm>
        <TitleTxt>VP SALES,STBT</TitleTxt>
        <AverageHoursPerWeekRt>50.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>232446</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>33489</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ELIZABETH WALTMAN</PersonNm>
        <TitleTxt>SVP COO (THRU 03/22)</TitleTxt>
        <AverageHoursPerWeekRt>49.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.0</AverageHoursPerWeekRltdOrgRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>212290</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>14085</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>BELINDA ANNA FLORES</PersonNm>
        <TitleTxt>SR. DIRECTOR, PRODUCT MGMT &amp; C</TitleTxt>
        <AverageHoursPerWeekRt>50.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>203569</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>22536</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>VIVIENNE SHELLEY MARSHALL</PersonNm>
        <TitleTxt>SR DIRECTOR, CENTER FOR ADVANC</TitleTxt>
        <AverageHoursPerWeekRt>50.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>188907</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>27824</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JOSE QUESADA</PersonNm>
        <TitleTxt>SR DIRECTOR, MFG, TRANSFUSION</TitleTxt>
        <AverageHoursPerWeekRt>50.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>191938</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>12053</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>BIOBRIDGE GLOBAL</PersonNm>
        <TitleTxt>SOLE MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>3.0</AverageHoursPerWeekRltdOrgRt>
        <InstitutionalTrusteeInd>X</InstitutionalTrusteeInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>1580329</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>172440</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>19</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>true</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <ContractorCompensationGrp>
        <ContractorName>
          <PersonNm>INCEPT CORP</PersonNm>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>4150 BELDON VILLAGE ST NW STE 205</AddressLine1Txt>
            <CityNm>CANTON</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>44718</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>DONOR RECRUITMENT</ServicesDesc>
        <CompensationAmt>476865</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <PersonNm>TANGO CARD INC</PersonNm>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>4700 42ND AVE SW430A</AddressLine1Txt>
            <CityNm>SEATTLE</CityNm>
            <StateAbbreviationCd>WA</StateAbbreviationCd>
            <ZIPCd>98116</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>DONOR INCENTIVES</ServicesDesc>
        <CompensationAmt>1275000</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <PersonNm>PRIORITY COURIER</PersonNm>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>10522 GAZELLE CLIFF</AddressLine1Txt>
            <CityNm>SAN ANTONIO</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>78245</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>COURIER SERVICES</ServicesDesc>
        <CompensationAmt>413893</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <PersonNm>FRANCIS COMMUNICATIONS INC</PersonNm>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>1870 AIR LANE DRIVE</AddressLine1Txt>
            <CityNm>NASHVILLE</CityNm>
            <StateAbbreviationCd>TN</StateAbbreviationCd>
            <ZIPCd>37210</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>DONOR INCENTIVES</ServicesDesc>
        <CompensationAmt>320103</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <PersonNm>GPI USA INC</PersonNm>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>2906 GREENVALLEY TRAIL DR</AddressLine1Txt>
            <CityNm>KATY</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>77449</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>SOFT MAINT&amp;HOST FEES</ServicesDesc>
        <CompensationAmt>495068</CompensationAmt>
      </ContractorCompensationGrp>
      <CntrctRcvdGreaterThan100KCnt>16</CntrctRcvdGreaterThan100KCnt>
      <RelatedOrganizationsAmt>480857</RelatedOrganizationsAmt>
      <AllOtherContributionsAmt>914171</AllOtherContributionsAmt>
      <NoncashContributionsAmt>4560</NoncashContributionsAmt>
      <TotalContributionsAmt>1395028</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>BLOOD &amp; TISSUE SERVICE FEES</Desc>
        <BusinessCd>621300</BusinessCd>
        <TotalRevenueColumnAmt>72037004</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>72037004</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>RENT FROM AFFILIATED EXEMPT ORGANIZATION</Desc>
        <BusinessCd>531120</BusinessCd>
        <TotalRevenueColumnAmt>3141937</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>3141937</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>RESEARCH &amp; DEVELOPMENT SUPPORT</Desc>
        <BusinessCd>541700</BusinessCd>
        <TotalRevenueColumnAmt>222214</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>222214</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>COVID-19 TESTING FEES</Desc>
        <BusinessCd>541700</BusinessCd>
        <TotalRevenueColumnAmt>18835081</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>18835081</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>94236236</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>1633</TotalRevenueColumnAmt>
        <ExclusionAmt>1633</ExclusionAmt>
      </InvestmentIncomeGrp>
      <IncmFromInvestBondProceedsGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
      </IncmFromInvestBondProceedsGrp>
      <RoyaltiesRevenueGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </RoyaltiesRevenueGrp>
      <RentalIncomeOrLossGrp>
        <RealAmt>0</RealAmt>
        <PersonalAmt>0</PersonalAmt>
      </RentalIncomeOrLossGrp>
      <NetRentalIncomeOrLossGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetRentalIncomeOrLossGrp>
      <GrossAmountSalesAssetsGrp>
        <OtherAmt>39000</OtherAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <OtherAmt>0</OtherAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <OtherAmt>39000</OtherAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>39000</TotalRevenueColumnAmt>
        <ExclusionAmt>39000</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <FundraisingGrossIncomeAmt>0</FundraisingGrossIncomeAmt>
      <FundraisingDirectExpensesAmt>0</FundraisingDirectExpensesAmt>
      <NetIncmFromFundraisingEvtGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetIncmFromFundraisingEvtGrp>
      <GamingGrossIncomeAmt>0</GamingGrossIncomeAmt>
      <GamingDirectExpensesAmt>0</GamingDirectExpensesAmt>
      <NetIncomeFromGamingGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetIncomeFromGamingGrp>
      <GrossSalesOfInventoryAmt>0</GrossSalesOfInventoryAmt>
      <CostOfGoodsSoldAmt>0</CostOfGoodsSoldAmt>
      <NetIncomeOrLossGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetIncomeOrLossGrp>
      <OtherRevenueMiscGrp>
        <Desc>PURCHASE REBATES</Desc>
        <BusinessCd>621300</BusinessCd>
        <TotalRevenueColumnAmt>455588</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>455588</RelatedOrExemptFuncIncomeAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueMiscGrp>
        <Desc>MISCELLANEOUS</Desc>
        <TotalRevenueColumnAmt>182046</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>182046</RelatedOrExemptFuncIncomeAmt>
      </OtherRevenueMiscGrp>
      <MiscellaneousRevenueGrp>
        <TotalRevenueColumnAmt>182046</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>182046</RelatedOrExemptFuncIncomeAmt>
      </MiscellaneousRevenueGrp>
      <OtherRevenueTotalAmt>637634</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>96309531</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>94873870</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>40633</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>439561</TotalAmt>
        <ProgramServicesAmt>439561</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>0</TotalAmt>
      </GrantsToDomesticIndividualsGrp>
      <ForeignGrantsGrp>
        <TotalAmt>0</TotalAmt>
      </ForeignGrantsGrp>
      <BenefitsToMembersGrp>
        <TotalAmt>0</TotalAmt>
      </BenefitsToMembersGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>543653</TotalAmt>
        <ProgramServicesAmt>543653</ProgramServicesAmt>
      </CompCurrentOfcrDirectorsGrp>
      <CompDisqualPersonsGrp>
        <TotalAmt>0</TotalAmt>
      </CompDisqualPersonsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>19270942</TotalAmt>
        <ProgramServicesAmt>19270942</ProgramServicesAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>925618</TotalAmt>
        <ProgramServicesAmt>925618</ProgramServicesAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>2086145</TotalAmt>
        <ProgramServicesAmt>2086145</ProgramServicesAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>1316616</TotalAmt>
        <ProgramServicesAmt>1316616</ProgramServicesAmt>
      </PayrollTaxesGrp>
      <FeesForServicesManagementGrp>
        <TotalAmt>1847600</TotalAmt>
        <ManagementAndGeneralAmt>1847600</ManagementAndGeneralAmt>
      </FeesForServicesManagementGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>7984</TotalAmt>
        <ProgramServicesAmt>7984</ProgramServicesAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>0</TotalAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesLobbyingGrp>
        <TotalAmt>0</TotalAmt>
      </FeesForServicesLobbyingGrp>
      <FeesForServicesProfFundraising>
        <TotalAmt>0</TotalAmt>
      </FeesForServicesProfFundraising>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>0</TotalAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>7946954</TotalAmt>
        <ProgramServicesAmt>7946966</ProgramServicesAmt>
        <ManagementAndGeneralAmt>-12</ManagementAndGeneralAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>530054</TotalAmt>
        <ProgramServicesAmt>530054</ProgramServicesAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>388015</TotalAmt>
        <ProgramServicesAmt>388015</ProgramServicesAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>2183566</TotalAmt>
        <ProgramServicesAmt>2183566</ProgramServicesAmt>
      </InformationTechnologyGrp>
      <RoyaltiesGrp>
        <TotalAmt>0</TotalAmt>
      </RoyaltiesGrp>
      <OccupancyGrp>
        <TotalAmt>2142532</TotalAmt>
        <ProgramServicesAmt>2142532</ProgramServicesAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>871005</TotalAmt>
        <ProgramServicesAmt>871005</ProgramServicesAmt>
      </TravelGrp>
      <PymtTravelEntrtnmntPubOfclGrp>
        <TotalAmt>0</TotalAmt>
      </PymtTravelEntrtnmntPubOfclGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>29410</TotalAmt>
        <ProgramServicesAmt>29410</ProgramServicesAmt>
      </ConferencesMeetingsGrp>
      <InterestGrp>
        <TotalAmt>5077</TotalAmt>
        <ProgramServicesAmt>5077</ProgramServicesAmt>
      </InterestGrp>
      <PaymentsToAffiliatesGrp>
        <TotalAmt>0</TotalAmt>
      </PaymentsToAffiliatesGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>2369750</TotalAmt>
        <ProgramServicesAmt>2369750</ProgramServicesAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>88487</TotalAmt>
        <ManagementAndGeneralAmt>88487</ManagementAndGeneralAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>TESTING EXPENSES &amp; SUPPLIES</Desc>
        <TotalAmt>27525137</TotalAmt>
        <ProgramServicesAmt>27525137</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>CUSTOMER FREIGHT</Desc>
        <TotalAmt>2445668</TotalAmt>
        <ProgramServicesAmt>2445668</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>SUPPORT &amp; ADMINISTRATIVE FEES</Desc>
        <TotalAmt>20765218</TotalAmt>
        <ManagementAndGeneralAmt>20765218</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>DONOR INCENTIVES</Desc>
        <TotalAmt>2131946</TotalAmt>
        <ProgramServicesAmt>2131946</ProgramServicesAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>821061</TotalAmt>
        <ProgramServicesAmt>821061</ProgramServicesAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>96681999</TotalAmt>
        <ProgramServicesAmt>73980706</ProgramServicesAmt>
        <ManagementAndGeneralAmt>22701293</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>5219491</BOYAmt>
        <EOYAmt>3691783</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>125000</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <AccountsReceivableGrp>
        <BOYAmt>19787150</BOYAmt>
        <EOYAmt>10347136</EOYAmt>
      </AccountsReceivableGrp>
      <ReceivablesFromOfficersEtcGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </ReceivablesFromOfficersEtcGrp>
      <RcvblFromDisqualifiedPrsnGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </RcvblFromDisqualifiedPrsnGrp>
      <OthNotesLoansReceivableNetGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </OthNotesLoansReceivableNetGrp>
      <InventoriesForSaleOrUseGrp>
        <BOYAmt>3003409</BOYAmt>
        <EOYAmt>2254389</EOYAmt>
      </InventoriesForSaleOrUseGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>594229</BOYAmt>
        <EOYAmt>529301</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>66172271</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>40455476</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>27352707</BOYAmt>
        <EOYAmt>25716795</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>3187930</BOYAmt>
        <EOYAmt>3187930</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <InvestmentsOtherSecuritiesGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </InvestmentsOtherSecuritiesGrp>
      <InvestmentsProgramRelatedGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </InvestmentsProgramRelatedGrp>
      <IntangibleAssetsGrp>
        <BOYAmt>1361099</BOYAmt>
        <EOYAmt>1361099</EOYAmt>
      </IntangibleAssetsGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>107980</BOYAmt>
        <EOYAmt>2787995</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>60738995</BOYAmt>
        <EOYAmt>49876428</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>10083483</BOYAmt>
        <EOYAmt>4825044</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <GrantsPayableGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </GrantsPayableGrp>
      <DeferredRevenueGrp>
        <BOYAmt>56600</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </DeferredRevenueGrp>
      <TaxExemptBondLiabilitiesGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </TaxExemptBondLiabilitiesGrp>
      <EscrowAccountLiabilityGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </EscrowAccountLiabilityGrp>
      <LoansFromOfficersDirectorsGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </LoansFromOfficersDirectorsGrp>
      <MortgNotesPyblScrdInvstPropGrp>
        <BOYAmt>14352254</BOYAmt>
        <EOYAmt>13292375</EOYAmt>
      </MortgNotesPyblScrdInvstPropGrp>
      <UnsecuredNotesLoansPayableGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </UnsecuredNotesLoansPayableGrp>
      <OtherLiabilitiesGrp>
        <BOYAmt>27448498</BOYAmt>
        <EOYAmt>33617336</EOYAmt>
      </OtherLiabilitiesGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>51940835</BOYAmt>
        <EOYAmt>51734755</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>8339833</BOYAmt>
        <EOYAmt>-2505729</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <DonorRestrictionNetAssetsGrp>
        <BOYAmt>458327</BOYAmt>
        <EOYAmt>647402</EOYAmt>
      </DonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>8798160</BOYAmt>
        <EOYAmt>-1858327</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>60738995</BOYAmt>
        <EOYAmt>49876428</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <InfoInScheduleOPartXIInd>X</InfoInScheduleOPartXIInd>
      <ReconcilationRevenueExpnssAmt>-372468</ReconcilationRevenueExpnssAmt>
      <OtherChangesInNetAssetsAmt>-10284019</OtherChangesInNetAssetsAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>true</FSAuditedInd>
      <FSAuditedBasisGrp>
        <ConsolidatedBasisFinclStmtInd>X</ConsolidatedBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>true</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>false</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="IRS990ScheduleA">
      <PubliclySupportedOrg509a2Ind>X</PubliclySupportedOrg509a2Ind>
      <GiftsGrantsContrisRcvd509Grp>
        <CurrentTaxYearMinus4YearsAmt>634256</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>222644</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>4200546</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>854201</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1395028</CurrentTaxYearAmt>
        <TotalAmt>7306675</TotalAmt>
      </GiftsGrantsContrisRcvd509Grp>
      <GrossReceiptsAdmissionsGrp>
        <CurrentTaxYearMinus4YearsAmt>42769712</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>47981732</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>70709097</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>130991601</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>94873870</CurrentTaxYearAmt>
        <TotalAmt>387326012</TotalAmt>
      </GrossReceiptsAdmissionsGrp>
      <GrossReceiptsNonUnrltBusGrp>
        <TotalAmt>0</TotalAmt>
      </GrossReceiptsNonUnrltBusGrp>
      <TaxRevLeviedOrgnztnlBnft509Grp>
        <TotalAmt>0</TotalAmt>
      </TaxRevLeviedOrgnztnlBnft509Grp>
      <GovtFurnSrvcFcltsVl509Grp>
        <TotalAmt>0</TotalAmt>
      </GovtFurnSrvcFcltsVl509Grp>
      <Total509Grp>
        <CurrentTaxYearMinus4YearsAmt>43403968</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>48204376</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>74909643</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>131845802</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>96268898</CurrentTaxYearAmt>
        <TotalAmt>394632687</TotalAmt>
      </Total509Grp>
      <AmountsRcvdDsqlfyPersonGrp>
        <CurrentTaxYearMinus4YearsAmt>491681</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>67644</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>1238099</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>167469</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>480857</CurrentTaxYearAmt>
        <TotalAmt>2445750</TotalAmt>
      </AmountsRcvdDsqlfyPersonGrp>
      <SubstantialContributorsAmtGrp>
        <TotalAmt>0</TotalAmt>
      </SubstantialContributorsAmtGrp>
      <SubstAndDsqlfyPrsnsTotGrp>
        <CurrentTaxYearMinus4YearsAmt>491681</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>67644</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>1238099</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>167469</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>480857</CurrentTaxYearAmt>
        <TotalAmt>2445750</TotalAmt>
      </SubstAndDsqlfyPrsnsTotGrp>
      <PublicSupportTotal509Amt>392186937</PublicSupportTotal509Amt>
      <GrossInvestmentIncome509Grp>
        <CurrentTaxYearMinus4YearsAmt>28698</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>56613</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>39393</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>46030</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1633</CurrentTaxYearAmt>
        <TotalAmt>172367</TotalAmt>
      </GrossInvestmentIncome509Grp>
      <Post1975UBTIGrp>
        <CurrentTaxYearMinus4YearsAmt>19728</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>14531</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>11508</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>0</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>0</CurrentTaxYearAmt>
        <TotalAmt>45767</TotalAmt>
      </Post1975UBTIGrp>
      <InvestmentIncomeAndUBTIGrp>
        <CurrentTaxYearMinus4YearsAmt>48426</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>71144</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>50901</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>46030</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1633</CurrentTaxYearAmt>
        <TotalAmt>218134</TotalAmt>
      </InvestmentIncomeAndUBTIGrp>
      <NetIncomeFromOtherUBIGrp>
        <TotalAmt>0</TotalAmt>
      </NetIncomeFromOtherUBIGrp>
      <OtherIncome509Grp>
        <TotalAmt>0</TotalAmt>
      </OtherIncome509Grp>
      <TotalSupportCalendarYearGrp>
        <CurrentTaxYearMinus4YearsAmt>43452394</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>48275520</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>74960544</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>131891832</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>96270531</CurrentTaxYearAmt>
        <TotalAmt>394850821</TotalAmt>
      </TotalSupportCalendarYearGrp>
      <PublicSupportCY509Pct>0.99325</PublicSupportCY509Pct>
      <PublicSupportPY509Pct>0.99284</PublicSupportPY509Pct>
      <InvestmentIncomeCYPct>0.00055</InvestmentIncomeCYPct>
      <InvestmentIncomePYPct>0.00090</InvestmentIncomePYPct>
      <ThirtyThrPctSuprtTestsCY509Ind>X</ThirtyThrPctSuprtTestsCY509Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="IRS990ScheduleB">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="IRS990ScheduleD">
      <ArtPublicExhibitionAmountsGrp />
      <HeldWorksArtGrp />
      <CYMinus3YrEndwmtFundGrp />
      <CYMinus4YrEndwmtFundGrp />
      <LandGrp>
        <OtherCostOrOtherBasisAmt>2920989</OtherCostOrOtherBasisAmt>
        <BookValueAmt>2920989</BookValueAmt>
      </LandGrp>
      <BuildingsGrp>
        <OtherCostOrOtherBasisAmt>37151860</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>20236765</DepreciationAmt>
        <BookValueAmt>16915095</BookValueAmt>
      </BuildingsGrp>
      <LeaseholdImprovementsGrp>
        <OtherCostOrOtherBasisAmt>1127462</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>430309</DepreciationAmt>
        <BookValueAmt>697153</BookValueAmt>
      </LeaseholdImprovementsGrp>
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>15788548</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>12556016</DepreciationAmt>
        <BookValueAmt>3232532</BookValueAmt>
      </EquipmentGrp>
      <OtherLandBuildingsGrp>
        <OtherCostOrOtherBasisAmt>9183412</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>7232386</DepreciationAmt>
        <BookValueAmt>1951026</BookValueAmt>
      </OtherLandBuildingsGrp>
      <TotalBookValueLandBuildingsAmt>25716795</TotalBookValueLandBuildingsAmt>
      <OtherAssetsOrgGrp>
        <Desc>RIGHT-OF-USE ASSETS - LEASES</Desc>
        <BookValueAmt>2027060</BookValueAmt>
      </OtherAssetsOrgGrp>
      <OtherAssetsOrgGrp>
        <Desc>LONG TERM INVESTMENTS</Desc>
        <BookValueAmt>109534</BookValueAmt>
      </OtherAssetsOrgGrp>
      <OtherAssetsOrgGrp>
        <Desc>INTEREST RATE SWAP</Desc>
        <BookValueAmt>651401</BookValueAmt>
      </OtherAssetsOrgGrp>
      <TotalBookValueOtherAssetsAmt>2787995</TotalBookValueOtherAssetsAmt>
      <FederalIncomeTaxLiabilityAmt>0</FederalIncomeTaxLiabilityAmt>
      <OtherLiabilitiesOrgGrp>
        <Desc>INTERCOMPANY PAYABLES</Desc>
        <Amt>31572038</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>OPERATING LEASE LIABILITIES</Desc>
        <Amt>2045298</Amt>
      </OtherLiabilitiesOrgGrp>
      <TotalLiabilityAmt>33617336</TotalLiabilityAmt>
      <TotalRevEtcAuditedFinclStmtAmt>77285375</TotalRevEtcAuditedFinclStmtAmt>
      <OtherRevenueAmt>658292</OtherRevenueAmt>
      <RevenueNotReportedAmt>658292</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>76627083</RevenueSubtotalAmt>
      <OtherRevenuesNotIncludedAmt>19682448</OtherRevenuesNotIncludedAmt>
      <RevenueNotReportedFinclStmtAmt>19682448</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>96309531</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>74554958</TotExpnsEtcAuditedFinclStmtAmt>
      <ExpensesSubtotalAmt>74554958</ExpensesSubtotalAmt>
      <OtherExpensesNotIncludedAmt>22127041</OtherExpensesNotIncludedAmt>
      <ExpensesNotRptFinclStmtAmt>22127041</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>96681999</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE D, PART X, LINE 2</FormAndLineReferenceDesc>
        <ExplanationTxt>ASC 740 FOOTNOTE: MANAGEMENT HAS EVALUATED THEIR INCOME TAX POSITIONS UNDER THE GUIDANCE INCLUDED IN ASC 740. BASED ON THEIR REVIEW, MANAGEMENT HAS NOT IDENTIFIED ANY MATERIAL UNCERTAIN TAX POSITIONS TO BE RECORDED OR DISCLOSED IN THE FINANCIAL STATEMENTS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE D, PART XI, LINE 2D</FormAndLineReferenceDesc>
        <ExplanationTxt>AMOUNTS INCLUDED ON LINE 1 BUT NOT ON FORM 990: NET ASSETS RELEASED FROM RESTRICTIONS $ 658,292</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE D, PART XI, LINE 4B</FormAndLineReferenceDesc>
        <ExplanationTxt>AMOUNTS INCLUDED ON FORM 990 BUT NOT ON LINE 1: INCREASE IN TEMPORARILY RESTRICTED NET ASSETS $ 847,367 REVENUES &amp; CONTRIBUTIONS FROM COMMUNITY LABS $ 18,835,081 ------------ TOTAL $ 19,682,448</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE D, PART XII, LINE 4B</FormAndLineReferenceDesc>
        <ExplanationTxt>AMOUNTS INCLUDED ON FORM 990 NOT ON LINE 1: EXPENSES FROM COMMUNITY LABS $ 22,127,041</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleI documentId="IRS990ScheduleI">
      <GrantRecordsMaintainedInd>true</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>QUALTEX LABORATORIES</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>6211 IH 10 WEST</AddressLine1Txt>
          <CityNm>SAN ANTONIO</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>78201</ZIPCd>
        </USAddress>
        <RecipientEIN>208429619</RecipientEIN>
        <IRCSectionDesc>501 (C)(3)</IRCSectionDesc>
        <NonCashAssistanceAmt>439561</NonCashAssistanceAmt>
        <NonCashAssistanceDesc>FIXED ASSETS AND INV</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>TESTING</PurposeOfGrantTxt>
      </RecipientTable>
      <Total501c3OrgCnt>1</Total501c3OrgCnt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE I, PART I, LINE 2</FormAndLineReferenceDesc>
        <ExplanationTxt>MONITORING THE USE OF GRANT FUNDS: COMMUNITY LABS MADE A ONE-TIME NON CASH CONTRIBUTION TO QUALTEX LABORATORIES.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="IRS990ScheduleJ">
      <SeverancePaymentInd>false</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>false</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>false</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>false</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>false</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>true</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>true</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>false</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>false</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>ELIZABETH WALTMAN</PersonNm>
        <TitleTxt>SVP COO (THRU 03/22)</TitleTxt>
        <BaseCompensationFilingOrgAmt>121614</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>88415</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>2261</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>10038</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>4047</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>226375</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>ADRIENNE MENDOZA</PersonNm>
        <TitleTxt>SVP, COO STBT (EFF 04/22)</TitleTxt>
        <BaseCompensationFilingOrgAmt>253866</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>42550</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>2657</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>18030</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>9448</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>326551</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>JOSE QUESADA</PersonNm>
        <TitleTxt>SR DIRECTOR, MFG, TRANSFUSION</TitleTxt>
        <BaseCompensationFilingOrgAmt>173140</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>15956</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>2842</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>11451</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>602</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>203991</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>BELINDA ANNA FLORES</PersonNm>
        <TitleTxt>SR. DIRECTOR, PRODUCT MGMT &amp; C</TitleTxt>
        <BaseCompensationFilingOrgAmt>150684</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>50801</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>2084</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>12361</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>10175</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>226105</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>HARRY DANIEL IRIZARRY</PersonNm>
        <TitleTxt>VP SALES,STBT</TitleTxt>
        <BaseCompensationFilingOrgAmt>197437</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>31421</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>3588</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>14264</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>19225</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>265935</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>SAMANTHA GOMEZ NGAMSUNTIKUL</PersonNm>
        <TitleTxt>ASSOCIATE MEDICAL DIRECTOR</TitleTxt>
        <BaseCompensationFilingOrgAmt>224989</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>25000</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>2117</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>15506</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>19469</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>287081</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>VIVIENNE SHELLEY MARSHALL</PersonNm>
        <TitleTxt>SR DIRECTOR, CENTER FOR ADVANC</TitleTxt>
        <BaseCompensationFilingOrgAmt>169042</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>17674</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>2191</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>10968</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>16856</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>216731</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE J, PART I, LINE 3</FormAndLineReferenceDesc>
        <ExplanationTxt>METHOD USED TO ESTABLISH THE TOP MANAGEMENT OFFICIAL'S COMPENSATION: THE ORGANIZATION RELIED ON BIOBRIDGE GLOBAL'S PROCESS THAT USED ONE OR MORE OF THE METHODS LISTED IN SCHEDULE J, PART I, LINE 3 TO ESTABLISH THE TOP MANAGEMENT OFFICIAL'S COMPENSATION.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE J, PART I, LINE 6</FormAndLineReferenceDesc>
        <ExplanationTxt>COMPENSATION CONTINGENT ON ORGANIZATION'S EARNINGS: THE ORGANIZATION RELIED ON BIOBRIDGE GLOBAL'S PROCESS OF DETERMINING THE COMPENSATION CONTINGENT ON THE ORGANIZATION'S EARNINGS. THE PROCESS IS DISCLOSED ON THEIR FORM 990.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleJ>
    <IRS990ScheduleN documentId="IRS990ScheduleN">
      <LiquidationOfAssetsTableGrp />
      <DispositionOfAssetsDetail>
        <AssetsDistriOrExpnssPaidDesc>Community Labs</AssetsDistriOrExpnssPaidDesc>
        <DistributionDt>2022-07-01</DistributionDt>
        <FairMarketValueOfAssetAmt>8948736</FairMarketValueOfAssetAmt>
        <MethodOfFMVDeterminationTxt>BOOK COST</MethodOfFMVDeterminationTxt>
        <EIN>746385152</EIN>
        <PersonNm>kronkosky charitable foundation</PersonNm>
        <USAddress>
          <AddressLine1Txt>112 East Pecan Suite 830</AddressLine1Txt>
          <CityNm>San Antonio</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>78205</ZIPCd>
        </USAddress>
        <IRCSectionTxt>501(C)(3)</IRCSectionTxt>
      </DispositionOfAssetsDetail>
      <DirectorOfSuccessor2Ind>false</DirectorOfSuccessor2Ind>
      <EmployeeOfSuccessor2Ind>false</EmployeeOfSuccessor2Ind>
      <OwnerOfSuccessor2Ind>false</OwnerOfSuccessor2Ind>
      <ReceiveCompensation2Ind>false</ReceiveCompensation2Ind>
    </IRS990ScheduleN>
    <IRS990ScheduleO documentId="IRS990ScheduleO">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART I, LINE 1</FormAndLineReferenceDesc>
        <ExplanationTxt>ORGANIZATION'S MISSION: THE SOUTH TEXAS BLOOD &amp; TISSUE CENTER SUPPLIES BLOOD TO MORE THAN 100 HOSPITALS IN SOUTH TEXAS AND SUPPORTS TISSUE, apheresis services, RESEARCH/NEW THERAPIES AND UMBILICAL CORD BLOOD/BIRTH TISSUE DONATIONS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART III, LINE 3</FormAndLineReferenceDesc>
        <ExplanationTxt>SIGNIFICANT CHANGES TO PROGRAM SERVICES: ON JULY 1, 2022, SOUTH TEXAS BLOOD &amp; TISSUE CENTER WITHDREW AS THE SOLE MEMBER OF COMMUNITY LABS, LLC AND CEASED TO BE THE SOLE MEMBER OF THE COMPANY. AS RESULT OF THE WITHDRAWAL, THE SOLE MEMBERSHIP INTEREST WAS TRANSFERRED TO THE ALBERT &amp; BESSIE MAE KRONKOSKY CHARITABLE FOUNDATION.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 6</FormAndLineReferenceDesc>
        <ExplanationTxt>CLASSES OF MEMBERS OR STOCKHOLDERS: BIOBRIDGE GLOBAL IS THE SOLE MEMBER OF THE CORPORATION.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 8A</FormAndLineReferenceDesc>
        <ExplanationTxt>DOCUMENTING MEETINGS OR WRITTEN ACTIONS UNDERTAKEN BY BOARD: MEETINGS HELD AND WRITTEN ACTIONS UNDERTAKEN WERE DOCUMENTED IN THE MINUTES OF THE MEETINGS OF BIOBRIDGE GLOBAL'S BOARD OF DIRECTORS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>PROCESS TO REVIEW THE FORM 990: THE ORGANIZATION ENGAGES AN OUTSIDE ACCOUNTING FIRM TO PREPARE THE FORM 990. ONCE PREPARED, THE RETURN IS REVIEWED BY THE FINANCIAL MANAGEMENT STAFF FROM BIOBRIDGE GLOBAL, A RELATED ORGANIZATION. A COPY OF THE FORM 990 IS PROVIDED TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS OF BIOBRIDGE GLOBAL PRIOR TO FILING.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>COMPLIANCE WITH CONFLICT OF INTEREST POLICY: A COPY OF THE ORGANIZATION'S CONFLICT OF INTEREST POLICY IS PROVIDED ANNUALLY TO ALL OFFICERS, KEY EMPLOYEES AND BOARD OF DIRECTORS OF BIOBRIDGE GLOBAL. IN ADDITION, QUESTIONNAIRES ARE GIVEN OUT ON AN ANNUAL BASIS TO ALL OFFICERS, KEY EMPLOYEES AND BOARD OF DIRECTORS WHICH COVER BUSINESS AND FAMILY RELATIONSHIPS AND VARIOUS ACTIVITIES THAT HAVE OCCURRED OVER THE COURSE OF THE YEAR. EVERY ATTEMPT IS MADE TO ENSURE THAT ALL FORMS ARE RETURNED. INDIVIDUALS WHO FAIL TO RETURN THE REQUESTED FORMS OR PROVIDE INCOMPLETE INFORMATION ARE CONTACTED BY THE ORGANIZATION. IN THE EVENT OF A CONFLICT OF INTEREST, THE MEMBER SUBJECT TO THE CONFLICT OF INTEREST MUST LEAVE THE DISCUSSION AND VOTING ON A TRANSACTION OR ARRANGEMENT THAT RESULTS IN A CONFLICT OF INTEREST. A COMMITTEE OF NON-INTERESTED REPRESENTATIVES SHALL BE APPOINTED TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. THE PARTY WITH A CONFLICT OF INTEREST IS NOT PERMITTED TO ADVOCATE TO OTHER REPRESENTATIVES PRIOR TO THE VOTE. THE COMMITTEE IS RESPONSIBLE FOR EXERCISING DUE DILIGENCE IN DETERMINING THAT THE TRANSACTION IS NOT MORE MATERIALLY ADVANTAGEOUS THAN A DEAL WITH A NON-INTERESTED TRANSACTION.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 15A</FormAndLineReferenceDesc>
        <ExplanationTxt>REVIEW OF TOP MANAGEMENT OFFICIAL'S COMPENSATION: IN DETERMINING THE TOP MANAGEMENT OFFICIAL'S COMPENSATION, THE ORGANIZATION RELIED ON BIOBRIDGE GLOBAL'S PROCESS TO ASSIST IN COMPENSATION DECISIONS. THE PROCESS OF DETERMINING THE TOP MANAGEMENT COMPENSATION IS DISCLOSED ON THEIR FORM 990.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 15B</FormAndLineReferenceDesc>
        <ExplanationTxt>REVIEW OF OTHER OFFICERS' COMPENSATION: THE ORGANIZATION RELIED ON BIOBRIDGE GLOBAL'S PROCESS TO ASSIST IN COMPENSATION DECISIONS. THE PROCESS OF DETERMINING OTHER OFFICERS' COMPENSATION IS DISCLOSED ON THEIR FORM 990.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC: ANY DOCUMENTS SUBJECT TO OPEN RECORD REQUIREMENTS ARE MADE AVAILABLE UPON REQUEST.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XI, LINE 9</FormAndLineReferenceDesc>
        <ExplanationTxt>OTHER CHANGES IN NET ASSETS OR FUND BALANCES: CHANGE IN INTEREST RATE SWAP $ 1,780,290 TRANSFER OF INTEREST IN COMMUNITY LABS, LLC $ (8,948,736) EQUITY TRANSFER BETWEEN RELATED ORGANIZATIONS $ (3,115,573) --------------- TOTAL $ (10,284,019)</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
    <IRS990ScheduleR documentId="IRS990ScheduleR">
      <IdDisregardedEntitiesGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>COMMUNITY LABS</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>6211 IH 10 WEST</AddressLine1Txt>
          <CityNm>SAN ANTONIO</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>78201</ZIPCd>
        </USAddress>
        <EIN>237379332</EIN>
        <PrimaryActivitiesTxt>COVID-19 TEST</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>TX</LegalDomicileStateCd>
        <TotalIncomeAmt>18835081</TotalIncomeAmt>
        <EndOfYearAssetsAmt>0</EndOfYearAssetsAmt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>SEE PART VII</BusinessNameLine1Txt>
        </DirectControllingEntityName>
      </IdDisregardedEntitiesGrp>
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>QUALTEX LABORATORIES</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>6211 IH 10 WEST</AddressLine1Txt>
          <CityNm>SAN ANTONIO</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>78201</ZIPCd>
        </USAddress>
        <EIN>208429619</EIN>
        <PrimaryActivitiesTxt>TEST PUB SFTY</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>AZ</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>501 (C) (3)</ExemptCodeSectionTxt>
        <PublicCharityStatusTxt>11</PublicCharityStatusTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>SEE PART VII</BusinessNameLine1Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>true</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>THE BLOOD &amp; TISSUE CENTER FOUNDATION</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>6211 IH 10 WEST</AddressLine1Txt>
          <CityNm>SAN ANTONIO</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>78201</ZIPCd>
        </USAddress>
        <EIN>431970952</EIN>
        <PrimaryActivitiesTxt>SUPPORT ORG</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>TX</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>501 (C) (3)</ExemptCodeSectionTxt>
        <PublicCharityStatusTxt>12 TYPE I</PublicCharityStatusTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>SEE PART VII</BusinessNameLine1Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>true</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>BIOBRIDGE GLOBAL</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>6211 IH 10 WEST</AddressLine1Txt>
          <CityNm>SAN ANTONIO</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>78201</ZIPCd>
        </USAddress>
        <EIN>454765222</EIN>
        <PrimaryActivitiesTxt>SUPPORT ORG</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>TX</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>501 (C) (3)</ExemptCodeSectionTxt>
        <PublicCharityStatusTxt>12 TYPE II</PublicCharityStatusTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>NA</BusinessNameLine1Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>false</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>GENCURE</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>6211 IH 10 WEST</AddressLine1Txt>
          <CityNm>SAN ANTONIO</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>78201</ZIPCd>
        </USAddress>
        <EIN>462216869</EIN>
        <PrimaryActivitiesTxt>CEL AND TIS S</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>TX</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>501 (C) (3)</ExemptCodeSectionTxt>
        <PublicCharityStatusTxt>10</PublicCharityStatusTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>SEE PART VII</BusinessNameLine1Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>true</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>ALLIANCE FOR COMM TRANSFUSION SERVICES</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>6211 IH 10 WEST</AddressLine1Txt>
          <CityNm>SAN ANTONIO</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>78201</ZIPCd>
        </USAddress>
        <EIN>454624346</EIN>
        <PrimaryActivitiesTxt>SEE PART VII</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>TX</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>501 (C) (3)</ExemptCodeSectionTxt>
        <PublicCharityStatusTxt>12 TYPE II</PublicCharityStatusTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>NA</BusinessNameLine1Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>false</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <ReceiptOfIntAnntsRntsRyltsInd>false</ReceiptOfIntAnntsRntsRyltsInd>
      <GiftGrntOrCapContriToOthOrgInd>false</GiftGrntOrCapContriToOthOrgInd>
      <GiftGrntCapContriFromOthOrgInd>true</GiftGrntCapContriFromOthOrgInd>
      <LoansOrGuaranteesToOtherOrgInd>false</LoansOrGuaranteesToOtherOrgInd>
      <LoansOrGuaranteesFromOthOrgInd>true</LoansOrGuaranteesFromOthOrgInd>
      <DivRelatedOrganizationInd>false</DivRelatedOrganizationInd>
      <AssetSaleToOtherOrgInd>false</AssetSaleToOtherOrgInd>
      <AssetPurchaseFromOtherOrgInd>false</AssetPurchaseFromOtherOrgInd>
      <AssetExchangeInd>false</AssetExchangeInd>
      <RentalOfFacilitiesToOthOrgInd>true</RentalOfFacilitiesToOthOrgInd>
      <RentalOfFcltsFromOthOrgInd>false</RentalOfFcltsFromOthOrgInd>
      <PerformOfServicesForOthOrgInd>false</PerformOfServicesForOthOrgInd>
      <PerformOfServicesByOtherOrgInd>true</PerformOfServicesByOtherOrgInd>
      <SharingOfFacilitiesInd>true</SharingOfFacilitiesInd>
      <PaidEmployeesSharingInd>true</PaidEmployeesSharingInd>
      <ReimbursementPaidToOtherOrgInd>true</ReimbursementPaidToOtherOrgInd>
      <ReimbursementPaidByOtherOrgInd>true</ReimbursementPaidByOtherOrgInd>
      <TransferToOtherOrgInd>true</TransferToOtherOrgInd>
      <TransferFromOtherOrgInd>false</TransferFromOtherOrgInd>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>THE BLOOD &amp; TISSUE CENTER FOUNDATION</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>C</TransactionTypeTxt>
        <InvolvedAmt>465919</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>BOOK COST</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>QUALTEX LABORATORIES</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>E</TransactionTypeTxt>
        <InvolvedAmt>13424600</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>BOOK COST</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>QUALTEX LABORATORIES</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>J</TransactionTypeTxt>
        <InvolvedAmt>1271646</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>BOOK COST</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>QUALTEX LABORATORIES</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>M</TransactionTypeTxt>
        <InvolvedAmt>5686395</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>BOOK COST</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>GENCURE</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>R</TransactionTypeTxt>
        <InvolvedAmt>3115573</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>BOOK COST</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE R, PART I, COLUMN F</FormAndLineReferenceDesc>
        <ExplanationTxt>IDENTIFICATION OF DISREGARDED ENTITIES: ON JULY 1, 2022, SOUTH TEXAS BLOOD &amp; TISSUE CENTER WITHDREW AS THE SOLE MEMBER OF COMMUNITY LABS, LLC AND CEASED TO BE THE SOLE MEMBER OF THE COMPANY.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE R, PART II, LINE 5, COLUMN B</FormAndLineReferenceDesc>
        <ExplanationTxt>PRIMARY ACTIVITY: THE PRIMARY ACTIVITY OF ALLIANCE FOR COMMUNITY TRANSFUSION SERVICES IS THE PROMOTION OF STANDARDIZATION AND EFFICIENCY.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE R, PART II, LINES 1, 2 &amp; 4, COLUMN F</FormAndLineReferenceDesc>
        <ExplanationTxt>DIRECT CONTROLLING ENTITY: THE ORGANIZATIONS SPECIFIED ARE ALL CONTROLLED BY BIOBRIDGE GLOBAL.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleR>
  </ReturnData>
</Return>
